About Exela Pharma
Exela Pharma is a company based in Lenoir (United States) founded in 2005 by Phanesh Koneru. Exela Pharma has raised $7.09 million across 5 funding rounds from investors including Premier. The company has 247 employees as of December 31, 2019. Exela Pharma offers products and services including Sterile Injectables and CDMO Services.
- Headquarter Lenoir, United States
- Employees 247 as on 31 Dec, 2019
- Founders Phanesh Koneru
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Exela Pharma Sciences Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.09 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
- Investors
-
Employee Count
247
as on Dec 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Exela Pharma
Exela Pharma offers a comprehensive portfolio of products and services, including Sterile Injectables and CDMO Services.
Develops and manufactures sterile injectables to address healthcare needs.
Provides R&D, manufacturing, and logistics for pharmaceutical clients.
People of Exela Pharma
Unlock access to complete
Funding Insights of Exela Pharma
Exela Pharma has successfully raised a total of $7.09M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Exela Pharma
Exela Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Premier.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cloud-based practice management software is provided for organizations.
|
Locked | Locked | Locked |
Investor details for Exela Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Exela Pharma
Investment portfolio details for Exela Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Exela Pharma
Detailed financials for Exela Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Exela Pharma Comparisons
Peer comparison for Exela Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Exela Pharma
Detailed competitors of Exela Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Exela Pharma
Complete news archive for Exela Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exela Pharma
Exela Pharma was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Exela Pharma is headquartered in Lenoir, United States. It is registered at Lenoir, North Carolina, United States.
Phanesh Koneru is the current CEO of Exela Pharma. They have also founded this company.
Exela Pharma is a funded company, having raised a total of $7.09M across 5 funding rounds to date.
As of Dec 31, 2019, the latest employee count at Exela Pharma is 247.
Exela Pharma was founded in 2005 and is headquartered in Lenoir, United States, within the pharmaceutical sector. Proprietary and generic sterile injectables are developed and produced, covering the full lifecycle from research and development through manufacturing and distribution. Contract development and manufacturing services are offered for liquid vials, IV bags, lyophilized vials, and pre-filled syringes. Regulatory support is also provided to clients.
Exela Pharma offers Sterile Injectables and CDMO Services.
Exela Pharma has 1 investor. Key investors include Premier.